At present, after assessment, the city has rated more than 20 A-level companies and announced it to the public in newspapers and television to promote A-level companies and expand their influence. In the future, we will also adopt tilting policies in related areas to support Class A companies and give full play to the role of state-owned enterprises as the main channel, thus stabilizing the market and reducing the price level. Implementation of a goods and a sign, clearly marked price, indicate the name, model, origin, manufacturers; strict implementation of price policies, implementation of national and local regulations on the rate of auto parts in and out, do not arbitrarily increase prices, do not buy short-selling, no increase in price; Not "principal", "rebate" and gift money; not over-reaching business; use "special invoices for auto parts sales" as required; no other bills are required for replacement; in accordance with relevant state taxation policies and financial management regulations, truthfully reflect turnover. , Pay taxes and fees in full and on time. We have done two things: We strictly prohibit the sale of counterfeit goods and we cooperate with the technical supervision department to conduct quality inspections on the parts sold. Once counterfeit and inferior commodities are detected, they are strictly dealt with and resolutely crack down on shoddy and deceptive behavior. According to the needs of the society, it is necessary to carry out arbitration business for auto parts disputes and accept disputes caused by the quality of parts. Up to now, we have accepted 3 cases. Through patience mediation, they have been properly handled, recovering losses of 1640 yuan for users. It not only facilitates the maintenance of the enterprise, but also enables the fixed-buyer buyer of the accessories distribution company, reducing intermediate links and bringing substantial benefits to both parties. At present, the city's auto parts distribution industry has achieved preliminary results in the management of the industry, the role of industry management has been recognized by the community, and is generally welcomed by auto repair companies. Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance. Enzalutamide Intermediate Cas No 143782-23-4,Enzalutamide Project Cas 143782-23-4,Enzalutamide Cas 915087-24-0,Enzalutamide Cas 609784-45-4 Â Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com
August 27, 2021